GO:0046491 L-methylmalonyl-CoA metabolic process: Propionate Catabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046491 describes the chemical reactions and pathways involving L-methylmalonyl-CoA, the L-enantiomer of 2-carboxypropanoyl-CoA, a key intermediate in propionate and odd-chain fatty acid catabolism.
• The pathway converts propionyl-CoA to succinyl-CoA via three enzymatic steps: propionyl-CoA carboxylase, methylmalonyl-CoA epimerase, and L-methylmalonyl-CoA mutase [1,4].
• L-methylmalonyl-CoA mutase requires adenosylcobalamin (vitamin B12) as a cofactor, linking this metabolic process directly to cobalamin status [2,7].
• Deficiency of methylmalonyl-CoA epimerase causes a rare organic aciduria that can mimic propionic aciduria, with elevated methylmalonic acid and 3-hydroxypropionic acid [1,8].
• Mutations in the mutase gene (MMUT) cause methylmalonic acidemia, a severe inherited metabolic disorder.
• CRISPR-based knockout, point-mutation, and knock-in models are powerful tools to dissect the enzymatic steps and disease mechanisms of this pathway [6,8].
Description
L-methylmalonyl-CoA metabolic process (GO:0046491) is a biological process that encompasses the chemical reactions and pathways involving L-methylmalonyl-CoA, the L-enantiomer of 2-carboxypropanoyl-CoA. This intermediate sits at the crossroads of propionate metabolism, which is essential for the breakdown of odd-numbered fatty acids, branched-chain amino acids, and other propionyl-CoA precursors in animals. The pathway is highly conserved and ultimately funnels carbon skeletons into the tricarboxylic acid cycle via succinyl-CoA. Understanding this process is critical because its dysfunction leads to organic acidemias, metabolic decompensation, and multi-organ pathology [1,7]. The core enzymatic steps of L-methylmalonyl-CoA metabolism involve propionyl-CoA carboxylase, methylmalonyl-CoA epimerase, and L-methylmalonyl-CoA mutase [1,4]. The mutase reaction requires adenosylcobalamin, a vitamin B12 derivative, making this pathway a sensitive indicator of cobalamin and folate status [2,7]. Research into this process has revealed that inherited defects in any of these enzymes produce distinct biochemical phenotypes, including elevated methylmalonic acid, 3-hydroxypropionic acid, and 2-methylcitric acid [1,8]. For researchers, GO:0046491 provides a precise ontological framework to annotate genes, interpret metabolomic data, and design mechanistic studies. The availability of CRISPR-engineered cell and animal models has accelerated the dissection of enzyme structure-function relationships and the development of therapeutic strategies for methylmalonic acidemia and related disorders [6,8].
L-methylmalonyl-CoA metabolic process At A Glance
| GO ID | GO:0046491 |
|---|---|
| GO term | L-methylmalonyl-CoA metabolic process |
| Ontology | biological_process |
| Synonym | L-methylmalonyl-CoA metabolism |
| Definition | The chemical reactions and pathways involving L-methylmalonyl-CoA, the L-enantiomer of 2-carboxypropanoyl-CoA. S-methylmalonyl-CoA is an intermediate in the beta oxidation of odd-numbered fatty acids in animals. |
| Major function | Conversion of L-methylmalonyl-CoA to succinyl-CoA, linking propionate catabolism to the TCA cycle |
| Key enzymes | Propionyl-CoA carboxylase, methylmalonyl-CoA epimerase, L-methylmalonyl-CoA mutase |
| Cofactor | Adenosylcobalamin (vitamin B12) |
| Related disorders | Methylmalonic acidemia, methylmalonyl-CoA epimerase deficiency, propionic acidemia |
What Is GO:0046491?
GO:0046491, L-methylmalonyl-CoA metabolic process, is defined as the chemical reactions and pathways involving L-methylmalonyl-CoA, the L-enantiomer of 2-carboxypropanoyl-CoA. S-methylmalonyl-CoA is an intermediate in the beta oxidation of odd-numbered fatty acids in animals. In simpler terms, it is the set of biochemical steps that convert L-methylmalonyl-CoA to downstream products, primarily succinyl-CoA, as part of propionate catabolism.
Why Is L-methylmalonyl-CoA metabolic process Important in Cell Biology?
L-methylmalonyl-CoA metabolic process is essential for normal energy metabolism and for preventing the accumulation of toxic metabolites. Defects in this pathway cause methylmalonic acidemia and related organic acidemias, which can present with metabolic acidosis, hyperammonemia, developmental delay, and early death [1,7]. Because the pathway depends on vitamin B12, it also serves as a functional readout of cobalamin status, and its impairment is observed in nutritional deficiency and inborn errors of metabolism [2,7]. Moreover, the pathway intersects with mitochondrial energy production and redox balance, making it relevant to broader cellular physiology.
• Provides a route for propionate and odd-chain fatty acid catabolism into the TCA cycle.
• Dysfunction causes methylmalonic acidemia, a life-threatening inherited metabolic disorder.
• Methylmalonyl-CoA epimerase deficiency can mimic propionic aciduria, complicating diagnosis.
• Requires vitamin B12, linking the pathway to nutritional and cobalamin-related disorders [2,7].
• Accumulation of methylmalonic acid is a biomarker for cobalamin deficiency and inborn errors.
• Serves as a model for studying enzyme cofactor chemistry and radical-based catalysis.
• Relevant to newborn screening and genetic counseling [1,8].
• CRISPR models enable functional validation of variants of uncertain significance [6,8].
• Pathway intermediates can influence mitochondrial function and oxidative stress.
• Target for therapeutic development including enzyme replacement and small-molecule chaperones.
What Happens During L-methylmalonyl-CoA metabolic process?
Propionyl-CoA carboxylation to D-methylmalonyl-CoA
In simple terms: First, propionyl-CoA is converted into D-methylmalonyl-CoA by adding a carboxyl group.
The initial step of the pathway is the ATP-dependent carboxylation of propionyl-CoA to D-methylmalonyl-CoA, catalyzed by propionyl-CoA carboxylase, a biotin-dependent enzyme. This reaction commits propionate from odd-chain fatty acids and amino acid catabolism to the methylmalonyl-CoA pathway. The enzyme is a mitochondrial heterodimer and its activity is essential for normal propionate disposal.
Epimerization of D-methylmalonyl-CoA to L-methylmalonyl-CoA
In simple terms: Next, the D-form is flipped into the L-form by an epimerase enzyme.
Methylmalonyl-CoA epimerase (MCEE) catalyzes the reversible interconversion of D-methylmalonyl-CoA and L-methylmalonyl-CoA [1,8]. This step is necessary because the subsequent mutase reaction is specific for the L-enantiomer. Deficiency of this enzyme leads to a biochemical phenotype resembling propionic aciduria, with elevated methylmalonic acid and 3-hydroxypropionic acid [1,8].
L-methylmalonyl-CoA mutase reaction to succinyl-CoA
In simple terms: Finally, L-methylmalonyl-CoA is rearranged into succinyl-CoA, which enters the energy-producing TCA cycle.
L-methylmalonyl-CoA mutase (MMUT) catalyzes the adenosylcobalamin-dependent rearrangement of L-methylmalonyl-CoA to succinyl-CoA [2,5]. This is the terminal step of the pathway and represents the entry point of propionate carbon into the TCA cycle. The enzyme uses a radical mechanism involving the cobalamin cofactor, and its dysfunction causes methylmalonic acidemia [2,6].
Compartmentalization and substrate channeling
In simple terms: These reactions occur inside mitochondria, where the enzymes are organized for efficient processing.
All three enzymatic steps of L-methylmalonyl-CoA metabolism occur in the mitochondrial matrix. The proximity of the enzymes may facilitate substrate channeling and coordinate the pathway with other mitochondrial processes such as the TCA cycle and fatty acid oxidation. Disruption of mitochondrial integrity can therefore impair flux through this pathway.
Regulation by vitamin B12 and metabolic status
In simple terms: The pathway depends on vitamin B12 and responds to the cell's nutritional state.
The mutase step requires adenosylcobalamin, and thus the pathway is sensitive to cobalamin availability [2,7]. In cobalamin or folate deficiency, methylmalonic acid accumulates, serving as a sensitive biomarker. Additionally, the pathway is influenced by the overall metabolic state, including the availability of propionyl-CoA precursors and mitochondrial energy demand.
Key Genes Involved in GO:0046491 L-methylmalonyl-CoA metabolic process
The following genes and proteins are central to L-methylmalonyl-CoA metabolic process and are frequently studied in the context of inherited metabolic disorders and metabolic engineering.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCCA | Propionyl-CoA carboxylase alpha subunit | Mutations cause propionic acidemia; target for metabolic studies |
| PCCB | Propionyl-CoA carboxylase beta subunit | Mutations cause propionic acidemia; biotin-dependent carboxylase |
| MCEE | Methylmalonyl-CoA epimerase | Deficiency mimics propionic aciduria; rare disease gene [1,8] |
| MMUT | L-methylmalonyl-CoA mutase | Mutations cause methylmalonic acidemia; requires vitamin B12 [2,6] |
| MMAA | Methylmalonic aciduria type A protein | Involved in cobalamin transport and mutase protection |
| MMAB | Methylmalonic aciduria type B protein | Involved in adenosylcobalamin synthesis |
| MMADHC | Methylmalonic aciduria cblD type | Defects affect cobalamin metabolism |
| LMBRD1 | LMBR1 domain containing 1 | Cobalamin metabolism; associated with methylmalonic acidemia |
| ABCD4 | ATP binding cassette subfamily D member 4 | Cobalamin transport; related to metabolic disorders |
| TCN2 | Transcobalamin 2 | Vitamin B12 transport; affects pathway flux |
| MTR | Methionine synthase | Links cobalamin to folate cycle; related to homocysteine |
| MTHFR | Methylenetetrahydrofolate reductase | Folate metabolism; interacts with B12 status |
| SUCLA2 | Succinyl-CoA ligase ADP-forming beta subunit | Mitochondrial TCA enzyme; downstream of pathway |
| SUCLG1 | Succinyl-CoA ligase alpha subunit | TCA cycle enzyme; potential interaction |
| ACADM | Medium-chain acyl-CoA dehydrogenase | Fatty acid oxidation; source of propionyl-CoA |
| HADHA | Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha | Odd-chain fatty acid oxidation; upstream of pathway |
| SLC25A1 | Solute carrier family 25 member 1 | Mitochondrial citrate carrier; related to metabolic flux |
How Is L-methylmalonyl-CoA metabolic process Regulated?
The L-methylmalonyl-CoA metabolic process is regulated at multiple levels. Enzyme activity depends on cofactor availability, particularly adenosylcobalamin for MMUT and biotin for propionyl-CoA carboxylase [2,4]. Transcriptional regulation of the involved genes responds to nutritional and hormonal signals, although specific transcription factors are not fully defined in the provided literature. Additionally, the pathway is subject to feedback inhibition by downstream metabolites and is integrated with mitochondrial energy status. Vitamin B12 deficiency leads to functional impairment of the mutase step, resulting in methylmalonic acid accumulation.
L-methylmalonyl-CoA metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MMUT | Methylmalonic acidemia | CRISPR knockout HEK293 or patient iPSC-derived hepatocytes |
| MCEE | Methylmalonyl-CoA epimerase deficiency | Knockout cell lines and point-mutation knock-in models [1,8] |
| PCCA | Propionic acidemia | Knockout mouse models and cell lines |
| PCCB | Propionic acidemia | CRISPR knockout in HepG2 cells |
| MMAA | Methylmalonic acidemia with cobalamin defect | Knock-in of patient variants in cell models |
Methylmalonic acidemia
Mutations in MMUT cause methylmalonic acidemia, an autosomal recessive disorder characterized by accumulation of methylmalonic acid, metabolic acidosis, and multi-organ complications. The disease can present in the neonatal period with lethargy, vomiting, and failure to thrive, and long-term management includes dietary restriction and carnitine supplementation. Research using CRISPR knockout models has helped elucidate the molecular consequences of MMUT deficiency.
Methylmalonyl-CoA epimerase deficiency
Biallelic mutations in MCEE cause methylmalonyl-CoA epimerase deficiency, a rare organic aciduria that can biochemically mimic propionic aciduria [1,8]. Patients may present with elevated methylmalonic acid, 3-hydroxypropionic acid, and 2-methylcitric acid. Structural and functional studies of pathogenic variants have provided insights into the enzyme's catalytic mechanism and stability.
Vitamin B12 and folate deficiency
Because L-methylmalonyl-CoA mutase requires adenosylcobalamin, vitamin B12 deficiency leads to functional impairment of this pathway and elevated methylmalonic acid. This biochemical marker is used clinically to assess cobalamin status, particularly in populations at risk such as the elderly and vegans. Folate deficiency can also affect related metabolic processes, including homocysteine metabolism.
Propionic acidemia
Defects in propionyl-CoA carboxylase (PCCA or PCCB) cause propionic acidemia, which shares clinical features with methylmalonic acidemia but has a distinct biochemical profile. The accumulation of propionyl-CoA and its derivatives can lead to secondary inhibition of the L-methylmalonyl-CoA pathway and mitochondrial dysfunction.
From L-methylmalonyl-CoA metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Enzyme catalytic mechanism | Point-mutation knock-in of active-site residues |
| Loss-of-function phenotype | CRISPR knockout of MMUT, MCEE, or PCC genes |
| Variant pathogenicity | Patient-derived point mutations knocked into isogenic cell lines |
| Metabolic flux analysis | Stable isotope tracing in knockout and wild-type cells |
| Protein localization and interactions | Tagged knock-in of endogenous genes |
| Therapeutic target validation | Overexpression of wild-type or mutant enzymes |
How to Study the L-methylmalonyl-CoA metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | Levels of methylmalonic acid and related metabolites | Diagnosis and monitoring of organic acidemias [1,7] |
| Stable isotope tracing | Flux through the pathway | Quantifying metabolic activity in cells |
| Enzyme activity assay | Catalytic activity of PCC, MCEE, or MMUT | Functional characterization of variants |
| Western blot | Protein expression levels | Assessing knockout or overexpression efficiency |
| Immunofluorescence | Subcellular localization | Confirming mitochondrial localization |
| CRISPR screening | Gene essentiality and pathway dependencies | Identifying modifiers of the pathway |
| RNA-seq | Transcriptional changes | Evaluating cellular response to pathway disruption |
| Structural crystallography | 3D structure of enzymes | Understanding catalytic mechanism [5,8] |
Metabolomics and stable isotope tracing
Mass spectrometry-based metabolomics is used to quantify methylmalonic acid, 3-hydroxypropionic acid, and other pathway intermediates in cells and body fluids [1,7]. Stable isotope tracing with 13C-propionate or 13C-odd-chain fatty acids allows measurement of flux through the L-methylmalonyl-CoA pathway.
Enzyme activity assays
Direct enzymatic assays for propionyl-CoA carboxylase, methylmalonyl-CoA epimerase, and L-methylmalonyl-CoA mutase can be performed on cell lysates or purified recombinant proteins. These assays typically monitor substrate conversion using HPLC or coupled spectrophotometric methods.
Genetic and genomic approaches
Sanger sequencing and next-generation sequencing panels are used to identify mutations in PCCA, PCCB, MCEE, and MMUT in patients with suspected organic acidemias [1,6]. CRISPR-based functional genomics can validate the impact of variants on enzyme function [6,8].
Structural biology and biophysics
X-ray crystallography and cryo-EM have been used to determine the structure of methylmalonyl-CoA epimerase and mutase, revealing the active site architecture and cofactor binding [5,8]. These studies inform the design of small-molecule chaperones and inhibitors.
How CRISPR Can Be Used to Study GO:0046491 L-methylmalonyl-CoA metabolic process
Knockout
CRISPR-Cas9 knockout of MMUT, MCEE, PCCA, or PCCB in cell lines such as HEK293 or HepG2 can recapitulate the biochemical phenotype of enzyme deficiency, including accumulation of methylmalonic acid. These models are useful for studying downstream metabolic and transcriptional consequences.
Point Mutation
Introducing patient-specific point mutations (e.g., in MCEE or MMUT) via CRISPR homology-directed repair allows functional assessment of variants of uncertain significance. This approach can distinguish pathogenic from benign variants and reveal structure-function relationships.
Knock-in
Knock-in of tagged versions of MMUT or MCEE (e.g., FLAG or GFP) enables endogenous protein localization, interaction, and stability studies without overexpression artifacts. This is particularly valuable for studying mitochondrial import and cofactor binding.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of wild-type or mutant enzymes can be used to test rescue of metabolic defects or to study gain-of-function effects. Overexpression models are also useful for producing recombinant enzyme for structural and biochemical studies.
How EDITGENE Supports L-methylmalonyl-CoA metabolic process Research
Researchers studying L-methylmalonyl-CoA metabolic process-related genes often need to determine whether a candidate gene is causally involved in the pathway, how specific mutations affect enzyme function, and what downstream metabolic consequences they produce. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for L-methylmalonyl-CoA metabolic process research.
Frequently Asked Questions About L-methylmalonyl-CoA metabolic process
What is L-methylmalonyl-CoA metabolic process?
It is the set of biochemical reactions involving L-methylmalonyl-CoA, an intermediate in propionate catabolism, ultimately converting it to succinyl-CoA.
What genes are involved in L-methylmalonyl-CoA metabolic process?
Key genes include PCCA, PCCB, MCEE, and MMUT, which encode the enzymes propionyl-CoA carboxylase, methylmalonyl-CoA epimerase, and L-methylmalonyl-CoA mutase [1,4].
What is the role of vitamin B12 in this pathway?
Vitamin B12 (adenosylcobalamin) is an essential cofactor for L-methylmalonyl-CoA mutase, and deficiency impairs the pathway, leading to methylmalonic acid accumulation [2,7].
What diseases are associated with defects in this pathway?
Methylmalonic acidemia, methylmalonyl-CoA epimerase deficiency, and propionic acidemia are the main disorders linked to this pathway [1,6].
How is methylmalonic acidemia diagnosed?
Diagnosis involves measuring elevated methylmalonic acid and other metabolites in blood and urine, followed by genetic testing of MMUT and related genes [6,7].
What are the symptoms of methylmalonyl-CoA epimerase deficiency?
Symptoms can mimic propionic aciduria and include metabolic acidosis, vomiting, lethargy, and elevated methylmalonic acid [1,8].
Can CRISPR be used to study this pathway?
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to dissect enzyme function and disease mechanisms [6,8].
What is the difference between L-methylmalonyl-CoA and D-methylmalonyl-CoA?
They are stereoisomers; only the L-form is a substrate for the mutase, and the epimerase interconverts the two [1,4].
How is L-methylmalonyl-CoA metabolic process related to odd-chain fatty acid oxidation?
Odd-chain fatty acids are broken down to propionyl-CoA, which enters this pathway for conversion to succinyl-CoA.
What research methods are used to study this pathway?
Common methods include LC-MS/MS metabolomics, enzyme activity assays, stable isotope tracing, and CRISPR-based genetic models [1,4,5].
Conclusion
L-methylmalonyl-CoA metabolic process (GO:0046491) is a fundamental mitochondrial pathway that links propionate catabolism to the TCA cycle. Its clinical importance is underscored by inherited disorders such as methylmalonic acidemia and methylmalonyl-CoA epimerase deficiency, as well as nutritional deficiencies in vitamin B12. Advances in CRISPR technology and metabolomics continue to illuminate the molecular details of this pathway and offer new avenues for therapeutic intervention. Researchers can leverage EDITGENE's services to build precise models and accelerate discoveries in this field.
References
- 1. Abily-Donval L et al.. 2017. Methylmalonyl-CoA Epimerase Deficiency Mimicking Propionic Aciduria.. Int J Mol Sci 18(11) PMID: 29104221
- 2. Takahashi-Iñiguez T et al.. 2012. Role of vitamin B12 on methylmalonyl-CoA mutase activity.. J Zhejiang Univ Sci B 13(6):423-37 PMID: 22661206
- 3. Reddy VS et al.. 2019. Implication of homocysteine in protein quality control processes.. Biochimie 165:19-31 PMID: 31269461
- 4. Halarnkar PP et al.. 1989. Comparative aspects of propionate metabolism.. Comp Biochem Physiol B 92(2):227-31 PMID: 2647392
- 5. Kolhouse JF et al.. 1988. L-methylmalonyl-CoA mutase from human placenta.. Methods Enzymol 166:407-14 PMID: 2907367
- 6. Ledley FD et al.. 1988. Molecular cloning of L-methylmalonyl-CoA mutase: gene transfer and analysis of mut cell lines.. Proc Natl Acad Sci U S A 85(10):3518-21 PMID: 2453061
- 7. Allen RH et al.. 1993. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency.. FASEB J 7(14):1344-53 PMID: 7901104
- 8. Heuberger K et al.. 2019. Genetic, structural, and functional analysis of pathogenic variations causing methylmalonyl-CoA epimerase deficiency.. Biochim Biophys Acta Mol Basis Dis 1865(6):1265-1272 PMID: 30682498
